OTC · Financial Statements

Radnostix, Inc. (INIS) Financial Statements

$0.06 OTC: INIS Market Cap $30.42M

Radnostix, Inc. most recently reported annual revenue of $13.0M, net profit of $-1.0M, revenue has compounded at 7.6% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$11.0M$12.0M$14.0M$13.0M
Operating Profit$0$1.0M$-1.0M$0$-1.0M
Net Profit$-2.0M$0$-1.0M$0$-1.0M
EPS$0.00$0.00$0.00$0.00$0.00
Op Margin0.0%8.2%-6.3%0.1%-7.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$16.0M$16.0M$17.0M$17.0M$18.0M
Total Liabilities$14.0M$12.0M$13.0M$13.0M$14.0M
Cash$0$2.0M$3.0M$2.0M$1.70T
Borrowings$4.0M$4.0M$8.0M$8.0M$4.84T

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-1.0M$1.0M$1.0M$1.0M
Investing Cash Flow$0$8.0M$0$-1.0M$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$2.0M$0$0$0
Free Cash Flow$0$-2.0M$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-26.82
FCF Yield-0.19%
Quick Ratio0.69
Interest Coverage-6.47
Return 1Y-47.73%
Return 3Y-28.12%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
INIS Overview INIS Dividend Run Stock Screener